PoliticusUSA is committed to delivering authentic news without the influence of corporate or billionaire interests. Support our efforts by becoming a subscriber.
In a recent move that has drawn both skepticism and acclaim, President Trump signed an executive order intended to reduce prescription drug prices for Americans.
The AP reported:
On Monday, President Donald Trump enacted a comprehensive executive order mandating that drug manufacturers must voluntarily lower the prices of prescription medications within 30 days, or they may face future constraints on government payments.
…
However, the actual effect of this order on the millions of Americans with private health insurance remains uncertain. The federal government primarily influences drug prices tied to Medicare and Medicaid.
Yet again, Trump attempts to impose regulations on the pharmaceutical industry through an executive order. It’s crucial to note that executive orders are not legislative acts and primarily govern the executive branch.
In essence, Trump’s directive is likely to have implications mainly for Medicare and Medicaid. Critics, including Senator Bernie Sanders, have labeled Trump’s executive order as little more than a façade.
Sen. Sanders articulated his concerns regarding the executive order, stating:
I concur with President Trump: It is outrageous that Americans pay exorbitantly high prices for prescription drugs. In some instances, we pay up to ten times more than our counterparts in other developed nations for identical medications. However, we need to be clear: the issue is not that drug prices in Europe and Canada are too low; it’s that the insatiably profit-driven pharmaceutical industry pocketed over $100 billion last year by exploiting American consumers.
Moreover, as Trump is well aware, his executive order is likely to be overturned by the courts. If he genuinely intends to effect meaningful change rather than simply issuing a press release, he should back a legislative initiative I will introduce soon, aimed at ensuring we do not pay more for prescription drugs than people in other major countries. If Republicans and Democrats unite on this legislation, we could pass it within weeks.
Sen. Sanders made a compelling point. If Trump were genuinely committed to lowering prescription drug prices, he would encourage Republican collaboration with Democrats, resulting in a bill ready for passage in a matter of weeks.
However, that’s unlikely to happen because Trump lacks earnestness in this matter.
His executive order on prescription drugs appears to be more of a performance than a policy shift, designed to create the illusion of action while ultimately achieving little of substance. Trump is acutely aware that the courts are poised to reject this measure, yet he presents it as a proactive effort while his presidency continues to grapple with failures, including attempts to undermine healthcare in pursuit of tax cuts for the wealthy.
What are your thoughts on Sen. Sanders’s critique of Trump’s executive order? We welcome your comments below.
